Over the past several years there has been increasing reports of JAK inhibitors being used to treat recalcitrant alopecia areata with excellent results in the majority of patients. Currently it is being explored as a potential topical treatment option for treating alopecia areata as well. Overall patients and JAK inhibitors do well with minimal to no side effects but there are potentially serious medical side effects that can occur. Currently, it is not covered by insurance nor FDA approved for alopecia areata. Hopefully, in the near future with more positive data, it will be approved and be an important new treatment option for patients with this devastating hair loss condition.
Below is our written information handout for patients considering oral minoxidil.
These are the first two CME articles on hair transplantation to ever be published in the leading peer reviewed journal in our field. I am proud to be one of its authors.
During the American Academy of Dermatology (AAD) virtual meeting experience, I was happy to participate in this very informative session on innovative therapeutic tools to slow hair loss and increase hair growth.
Fascinating article demonstrating how there is still so much to learn about the role of hair.
Medical therapy for Male and Female pattern hair loss
In this review, PRP was shown to be a safe and effective treatment for male and female pattern hair loss.